Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions

Ciurea, 2015, Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia, Blood, 126, 1033, 10.1182/blood-2015-04-639831 Di, 2014, Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors, Biol Blood Marrow Transplant, 20, 1975, 10.1016/j.bbmt.2014.08.013 Jaiswal, 2014, Comparable outcome of haploidentical and matched sibling donor peripheral blood stem cell transplantation following myeloablative conditioning for poor risk acute myeloid leukemia, Bone Marrow Transplant, 49, S209 Ravandi, 2010, Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy, Blood, 116, 5818, 10.1182/blood-2010-07-296392 Hemmati, 2015, Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome, Eur J Haematol, 95, 498, 10.1111/ejh.12522 Koh, 2011, Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation, J Exp Clin Cancer Res, 30, 36, 10.1186/1756-9966-30-36 Craddock, 2011, Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia, Leukemia, 25, 808, 10.1038/leu.2011.13 Duval, 2010, Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure, J Clin Oncol, 28, 3730, 10.1200/JCO.2010.28.8852 Chang, 2016, New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT, Bone Marrow Transplant, 51, 324, 10.1038/bmt.2015.288 Raj, 2014, Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning, Biol Blood Marrow Transplant, 20, 890, 10.1016/j.bbmt.2014.03.003 Jaiswal, 2015, Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe aplastic anemia, Bone Marrow Transplant, 50, 873, 10.1038/bmt.2015.50 Jaiswal, 2016, Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and melphalan-based conditioning, Biol Blood Marrow Transplant, 22, 499, 10.1016/j.bbmt.2015.11.010 Cooley, 2010, Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia, Blood, 116, 2411, 10.1182/blood-2010-05-283051 Ruggeri, 2007, Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value, Blood, 110, 433, 10.1182/blood-2006-07-038687 Grimwade, 2009, Independent prognostic factors for AML outcome, Hematol Am Soc Hematol Educ Progr, 1, 385, 10.1182/asheducation-2009.1.385 Jagasia, 2015, National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease. I. The 2014 Diagnosis and Staging Working Group report, Biol Blood Marrow Transplant, 21, 389, 10.1016/j.bbmt.2014.12.001 Soiffer, 2008, Donor lymphocyte infusions for acute myeloid leukaemia, Best Pract Res Clin Haematol, 21, 455, 10.1016/j.beha.2008.07.009 Wang, 2012, Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study, Clin Transplant, 26, 635, 10.1111/j.1399-0012.2012.01626.x Xuan, 2016, Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT, Oncotarget, 10.18632/oncotarget.8691 Kolb, 1995, Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients, Blood, 86, 2041, 10.1182/blood.V86.5.2041.bloodjournal8652041 Takami, 2014, Biol Blood Marrow Transplant, 20, 1785, 10.1016/j.bbmt.2014.07.010 Collins, 1997, Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation, J Clin Oncol, 15, 433, 10.1200/JCO.1997.15.2.433 Raiola, 2003, Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions, Bone Marrow Transplant, 31, 687, 10.1038/sj.bmt.1703883 Schmid, 2005, Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome, J Clin Oncol, 23, 5675, 10.1200/JCO.2005.07.061 Aversa, 1998, Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype, N Engl J Med, 339, 1186, 10.1056/NEJM199810223391702 Ghiso, 2015, DLI after haploidentical BMT with post-transplant CY, Bone Marrow Transplant, 50, 56, 10.1038/bmt.2014.217 Zeidan, 2014, HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantation, Biol Blood Marrow Transplant, 20, 314, 10.1016/j.bbmt.2013.11.020 Wang, 2012, Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis, Bone Marrow Transplant, 47, 1099, 10.1038/bmt.2011.213 Huang, 2007, Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation, Haematologica, 92, 414, 10.3324/haematol.10570 Jaiswal, 2016, Haploidentical transplantation in children with acute leukemia: the unresolved issues, Adv Hematol, 2016, 3467672, 10.1155/2016/3467672 Jaiswal, 2016, Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: the need to look beyond post-transplantation cyclophosphamide in younger children, Pediatr Transplant, 20, 675, 10.1111/petr.12724 Huang, 2008, Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia—feasibility and safety study, J Clin Immunol, 28, 390, 10.1007/s10875-008-9193-4 Ruggeri, 2006, Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation, Semin Cancer Biol, 16, 404, 10.1016/j.semcancer.2006.07.007 Ohata, 2011, Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen, Biol Blood Marrow Transplant, 17, 205, 10.1016/j.bbmt.2010.08.014